WallStreetZenWallStreetZen

NYSE: ABBV
ABBVIE INC Earnings & Revenue

ABBV past earnings growth

How has ABBV's earnings growth performed historically?
Company
150.54%
Industry
97.28%
Market
92.76%
ABBV's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ABBV's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ABBV's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ABBV past revenue growth

How has ABBV's revenue growth performed historically?
Company
13.01%
Industry
24.91%
Market
51.15%
ABBV's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ABBV's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ABBV's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ABBV earnings and revenue history

Current Revenue
$56.7B
Current Earnings
$12.5B
Current Profit Margin
22%

ABBV Return on Equity

Current Company
86.3%
Current Industry
42%
Current Market
38.4%
ABBV's Return on Equity (86.3%)... subscribe to Premium to read more.
High Return on Equity Performance

ABBV Return on Assets

Current Company
8.5%
Current Industry
10.4%
ABBV is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ABBV Return on Capital Employed

Current Company
14.77%
Current Industry
15.6%
ABBV has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ABBV vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ABBV$56.73B$24.70B$12.48B+16.69%+12.44%
LLY$29.32B$8.37B$6.13B+6.32%+26.58%
PFE$92.37B$32.34B$24.97B+11.92%+29.91%
MRK$53.98B$19.42B$14.18B+6.21%+28.84%
AZN$41.49B$7.05B-$1.06B+13.23%N/A

ABBVIE Earnings & Revenue FAQ

What were ABBV's earnings last quarter?

On Invalid Date, ABBVIE (NYSE: ABBV) reported Q1 2022 earnings per share (EPS) of $2.52, up 26% year over year. Total ABBVIE earnings for the quarter were $4.49 billion. In the same quarter last year, ABBVIE's earnings per share (EPS) was $2.00.

What was ABBV's earnings growth in the past year?

As of Q2 2022, ABBVIE's earnings has grown 150.54% year over year. This is 53.25 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 97.28%. ABBVIE's earnings in the past year totalled $12.48 billion.

What was ABBV's revenue last quarter?

On Invalid Date, ABBVIE (NYSE: ABBV) reported Q1 2022 revenue of $13.54 billion up 4.06% year over year. In the same quarter last year, ABBVIE's revenue was $13.01 billion.

What was ABBV's revenue growth in the past year?

As of Q2 2022, ABBVIE's revenue has grown 13.01% year over year. This is 11.9 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 24.91%. ABBVIE's revenue in the past year totalled $56.73 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.